Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 66
Titolo Data di pubblicazione Autori Tipo File Abstract
Low-dose ALEMTUZUMAB monotherapy in advanced chronic lymphocytic leukemia 2006 A. CortelezziM.C. PasquiniG. RedaF. RipamontiG. Lambertenghi Deliliers + Article (author) -
Low dose campath 1-H is highly effective and safe in advanced chronic CLL 2006 A. CortelezziM.C. PasquiniU. GianelliC. VenerG. RedaRIPAMONTI, FRANCESCOL. NobiliG. Lambertenghi Deliliers + Article (author) -
Fludarabine-Ifosfamide-Rituximab (FIR): a therapeutic option for chronic lymphocytic leukemia patients resistant to Chlorambucil 2006 A CortelezziMC PasquiniG RedaF RipamontiG Lambertenghi Deliliers. Article (author) -
Low-dose subcutaneous campath (CAM) is highly effective and safe in advanced and chemotherapy-refractory B-CLL : results of a prospectic and multicenter phase II study 2007 A. CortelezziM.C. PasquiniU. GianelliG. RedaG. Lambertenghi Deliliers + Article (author) -
Low dose dasatinib in refractory imatinib mesylate chronic myeloid leukemia : case report 2007 G. RedaF. RipamontiA. GardelliniC. VenerG. Lambertenghi Deliliers + Article (author) -
Role of dasatinib in PH '-positive acute lymphoblastic leukemia (ALL) after imatinib-based therapy failure : a case report 2007 A. CortelezziM.C. PasquiniG. RedaF. RipamontiA. GardelliniD. IntiniG. Lambertenghi Deliliers + Article (author) -
Conjunctival hemorrhagic events associated with imatinib 2007 C. VenerF. RipamontiG. RedaG. Lambertenghi Deliliers + Article (author) -
Conjunctival hemorrhagic events associated with imatinib mesylate 2007 C. VenerF. RipamontiG. RedaG. Lambertenghi Deliliers + Article (author) -
Evalutation of TIE2-expressing monocytes in myeloid disorders 2008 A. CortelezziG. GrittiS. LonatiI. SilvestrisG. RedaG. Lambertenghi Deliliers + Article (author) -
Myelodysplastic syndromes : microvascular density and immunohistochemical expression of the proteins controllin angiogenesis 2009 C. VenerU. GianelliG. RedaA. CortelezziG. Lambertenghi Deliliers + Article (author) -
Acute idiopathic polyneuropathy after subcutaneous alemtuzumab (AL) therapy in chronic lymphocytic leukemia (CLL) patients 2009 G. RedaR. CastelliK. Aprile von Hohenstaufen PuotiA. CortelezziN. Bresolin + Article (author) -
Relationship between expression of TLRS and disease activity in B-CLL 2009 G. RedaA. Cortelezzi + Article (author) -
Ineffective hematopoiesis and markers of angiogeneisis in myelodysplastic syndromes 2009 A. CortelezziG. GrittiS. LonatiI. SilvestrisAPRILE VON HOHENSTAUFEN PUOTI, KATHRIN IRA YASMINEG. RedaG. Lambertenghi Deliliers + Article (author) -
Iron metabolism and erythropoietic stress in myelodysplastic sindrome 2009 A. CortelezziG. RedaM.D. Cappellini + Article (author) -
Guillain Barrè syndrome in a chronic lymphocytic leukaemia (CLL) patient after subcutaneous alemtuzumab (A) therapy 2009 R. CastelliG. RedaA. CortelezziN. Bresolin + Article (author) -
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL) : results of a prospective, single-arm multicentre study 2009 A. CortelezziM.C. PasquiniGARDELLINI, ANGELOU. GianelliA. BossiG. RedaA. NeriG. Lambertenghi Deliliers + Article (author) -
New SMAC-Mimetic Compounds Strongly Induce In Vitro Apoptosis of Human Lymphocytes From Patients with Chronic Lymphocytic Leukemia 2010 Onida, FrancescoSaporiti, GiorgiaSeneci, PierfaustoReda, GianluigiCortelezzi, AgostinoDeliliers, Giorgio Lambertenghi + Article (author) -
Expression of TLRs in B-CLL: Relationship with Disease Activity 2011 Gianluigi RedaBruno FattizzoAlberto ZanellaAgostino Cortelezzi + Article (author) -
Hepcidin levels and their determinants in different types of myelodysplastic syndromes 2011 L. DucaA. CortelezziG. RedaM. D. Cappellini + Article (author) -
Lenalidomide in the treatment of chronic lymphocytic leukemia 2012 A. CortelezziM. SciuméG. Reda Article (author) -
Mostrati risultati da 1 a 20 di 66
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile